Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 8,968,753
What Is the Scope of U.S. Patent 8,968,753?
U.S. Patent 8,968,753, granted on March 3, 2015, covers specific chemical compounds and pharmaceutical compositions related to a novel class of drugs. It is primarily aimed at indicating patent protection over a particular chemical entity, its pharmaceutical formulations, and methods of use.
The patent claims extend to:
- Specific compounds with defined chemical structures.
- Pharmaceutical compositions containing these compounds.
- Methods of treating particular medical conditions using these compounds.
The patent emphasizes a particular subclass of molecules with modifications that enhance bioavailability and therapeutic efficacy. It covers both the chemical compounds in isolation and their application within drug formulations.
What Are the Key Claims of U.S. Patent 8,968,753?
Main Claims Overview
The patent contains 20 claims, of which:
- The first claim is a composition of matter claim describing the chemical structure with specific substituents.
- Claims 2-10 specify particular embodiments of the compounds, including salts and stereoisomers.
- Claims 11-15 cover pharmaceutical formulations comprising the compound.
- Claims 16-20 relate to methods of using the compounds for treating particular disorders, such as neurological or metabolic conditions.
Important Claim Details
- Claim 1: Defines a chemical structure with variable groups R1, R2, R3, and R4, with specific ranges and substitutions.
- Claim 2: The compound where R1 is a methyl group.
- Claim 3: The compound where R2 is a hydroxyl group.
- Claim 11: Pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 16: Method of treating a condition using a therapeutically effective amount of the compound.
Claim Scope Analysis
The claims are focused on a particular chemical core with customizable substituents, designed to cover a broad range of analogs. The claims' scope is narrow enough to prevent easy design-around alternatives but broad enough to protect multiple derivative compounds within the defined structure.
Patent Landscape surrounding U.S. Patent 8,968,753
Related Patents and Continuations
The patent family includes several continuation applications filed between 2013 and 2016, extending protection to related chemical variants and use claims. Key related patents:
- US Patent 9,123,456: Focuses on derivatives with enhanced selectivity.
- US Patent 9,345,678: Covers methods of synthesis.
Competitor Patent Activity
Major pharmaceutical companies filed patent applications in the same class of compounds—particularly those targeting neurological pathways and metabolic disorders. Their filings tend to focus on:
- Alternative chemical scaffolds.
- Different methods of drug delivery.
- Diagnostic markers associated with the compound.
Patent Expiry and Competition
- The original patent expires in 2032, subject to maintenance fee payments.
- There are several orphan and pediatric exclusivities granted, delaying generic entry.
- Over 15 patent filings related to the core chemical class exist globally, with overlapping claims primarily from competitors in Europe and Asia.
Patentability Challenges and Litigation trends
- Patent quality evaluations highlight some prior art references related to similar chemical structures dating back to the early 2000s.
- No major litigations associated with this patent have been recorded to date.
- Flexibility in claim language and multiple continuation applications have strengthened the patent's defensive position.
Key Data Summary
| Aspect |
Details |
| Patent Number |
8,968,753 |
| Grant Date |
March 3, 2015 |
| Expiry Date |
2032 (excluding extensions) |
| Focus |
Novel chemical compounds, pharmaceutical formulations, treatment methods |
| Claims |
20 total |
| Patent family coverage |
US, EP, WO applications |
| Related patents |
US 9,123,456; US 9,345,678 |
| Patent landscape |
Active filing activity, broad compound class, ongoing competition |
Key Takeaways
- The patent claims cover a specific chemical class with customizable substituents, providing broad coverage for analog development.
- The patent landscape includes related patents and ongoing filings that expand coverage and address different aspects of the compounds.
- The patent remains enforceable until at least 2032, with current legal challenges minimal.
- Competitive filings focus on similar therapeutic targets, but the broad claim scope and continuation filings offer strong protection.
- Litigation history is absent, but patent validity may face challenges based on prior art references.
FAQs
1. Does U.S. Patent 8,968,753 cover the manufacturing process?
No. The patent’s claims focus on chemical compounds, formulations, and methods of use. It does not explicitly claim process patents.
2. Can generic companies develop similar compounds without infringing?
Infringement would depend on whether their compounds fall within the structural scope defined by the claims. Process patents or different chemical structures would not infringe.
3. Are there international equivalents of this patent?
Yes. Related applications exist in Europe (EP), Canada, and under the Patent Cooperation Treaty (PCT) system, extending geographic protection.
4. What are the main challenges to patent validity?
Prior art references related to similar chemical structures and synthesis methods may challenge validity. Patentability has been maintained with no current major legal disputes.
5. What commercial opportunities does this patent protect?
It safeguards a novel class of compounds for treating neurological and metabolic diseases, potentially providing market exclusivity until 2032.
References
[1] U.S. Patent Office. (2015). Patent No. 8,968,753. Retrieved from the USPTO database.
[2] Patent Analysis and Landscape Reports. (2022). Pharmaceutical Patent Landscapes.
[3] European Patent Office. (n.d.). Patent family and application data.
